Tacrolimus and corticosteroids versus tacrolimus, corticosteroids and basiliximab for control of acute rejection in de novo liver transplant recipients: A matched analysis.

被引：0
|
作者：
Sauer, IM
Langrehr, JM
Pascher, A
Bechstein, WO
Neuhaus, P
机构：
来源：
TRANSPLANTATION | 2000年 / 69卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
212
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [41] MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients
    Baccarani, Umberto
    Velkoski, Jaqueline
    Pravisani, Riccardo
    Adani, Gian Luigi
    Lorenzin, Dario
    Cherchi, Vittorio
    Falzone, Bruno
    Baraldo, Massimo
    Risaliti, Andrea
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (09) : 2971 - 2973
  • [42] Usefulness of Tacrolimus without Basiliximab in Well-Matched Living-Donor Renal Transplant Recipients in Korea
    Baek, Chung Hee
    Kim, Ji Hyun
    Yu, Hoon
    Shin, Eunhye
    Cho, Hyungjin
    Kim, Hyosang
    Yang, Won Seok
    Han, Duck Jong
    Park, Su-Kil
    Experimental and Clinical Transplantation, 2016, 14 (04) : 389 - 393
  • [43] Individualized Bayesian Approach Dosing of Once-daily Tacrolimus (Advagraf®) in De Novo Liver Transplant Recipients
    Mas-Serrano, P.
    Gonzalo, R. L.
    Melgar, P.
    Alcazar, C. F.
    Pascual, S.
    Bellot, P.
    Rodriguez Soler, M.
    Carnicer, F.
    Boquera, M. L.
    Selva Otaolaurruchi, J.
    Gascon-Ros, I.
    Mariano, F.
    Gomez Salinas, L.
    Jaime, F.
    Lluis, F.
    TRANSPLANTATION, 2017, 101 (05) : 119 - 120
  • [44] Response to outcomes of African-American kidney-transplant recipients treated with sirolimus, tacrolimus, and corticosteroids
    Hricik, DE
    TRANSPLANTATION, 2003, 75 (04) : 573 - 573
  • [45] Pharmacokinetics of Sotrastaurin Combined With Tacrolimus or Mycophenolic Acid in De Novo Kidney Transplant Recipients
    Kovarik, John M.
    Steiger, Juerg U.
    Grinyo, Josep M.
    Rostaing, Lionel
    Arns, Wolfgang
    Dantal, Jacques
    Proot, Pieter
    Budde, Klemens
    TRANSPLANTATION, 2011, 91 (03) : 317 - 322
  • [46] Belatacept Vs. Tacrolimus: Clinical Outcomes in De Novo Kidney Transplant Recipients
    Wongsaroj, P.
    Kahwaji, J.
    Vo, A.
    Choi, J.
    Villicana, R.
    Peng, A.
    Jordan, S.
    TRANSPLANTATION, 2014, 98 : 457 - 457
  • [47] CLINICAL EXPERIENCE WITH THE USE OF LCP-TACROLIMUS IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS
    Jukic, Nikolina Basic
    Furic-Cunko, Vesna
    Juric, Ivana
    Bubic-Filipi, Ljubica
    TRANSPLANT INTERNATIONAL, 2017, 30 : 476 - 476
  • [48] A Prospective Randomized Open Study in Liver Transplant Recipients: Daclizumab, Mycophenolate Mofetil, and Tacrolimus Versus Tacrolimus and Steroids
    Otero, Alejandro
    Varo, Evaristo
    Ortiz de Urbina, Jorge
    Martin-Vivaldi, Rafael
    Cuervas-Mons, Valentin
    Gonzalez-Pinto, Ignacio
    Rimola, Antoni
    Bernardos, Angel
    Otero, Santiago
    Maldonado, Jorge
    Herrero, Jose I.
    Barrao, Elena
    Dominguez-Granados, Rosa
    LIVER TRANSPLANTATION, 2009, 15 (11) : 1542 - 1552
  • [49] Comparative pharmacokinetics of tacrolimus in de novo pediatric transplant recipients randomized to receive immediate- or prolonged-release tacrolimus
    Vondrak, Karel
    Dhawan, Anil
    Parisi, Francesco
    Grenda, Ryszard
    Debray, Dominique
    Marks, Stephen D.
    Webb, Nicholas J. A.
    Lachaux, Alain
    Kazeem, Gbenga
    Undre, Nasrullah
    PEDIATRIC TRANSPLANTATION, 2018, 22 (08)
  • [50] Efficacy and safety of tacrolimus in de novo pediatric transplant recipients randomized to receive immediate- or prolonged-release tacrolimus
    Vondrak, Karel
    Parisi, Francesco
    Dhawan, Anil
    Grenda, Ryszard
    Webb, Nicholas J. A.
    Marks, Stephen D.
    Debray, Dominique
    Holt, Richard C. L.
    Lachaux, Alain
    Kelly, Deirdre
    Kazeem, Gbenga
    Undre, Nasrullah
    CLINICAL TRANSPLANTATION, 2019, 33 (10)
12345